逸達新冠新藥二期臨床提前停止收案 下半年公布數據 - 經濟日報

4/28/2022 12:00:00 AM3 yearsago
by 記者謝柏宏／即時報導

逸達（6576）今（28）日表示，該公司開發新成分新藥MMP‐12抑制劑 FP‐025用於治療新冠重危症（severe ...

6576657628MMP12 FP025severe to criticalAcute Respiratory Distress Syndrome, ARDS Covid19 9990 COVID19 FP025 Standard of Care; SOC2021IDMC2022 ARDS COVID19 ARDS ARDSARDS / COVID19 10% 300 ARDSARDS … [+11 chars]

full article...